Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine in Takotsubo Syndrome
NCT05946772Phase 2Recruiting
- Sponsor
- Heidelberg University Hospital
- Start
- Feb 2025
- Primary completion
- Feb 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclosporine in Takotsubo cardiomyopathy (TCM), sponsored by Heidelberg University Hospital. Started Feb 2025; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
Takotsubo cardiomyopathy (TCM)
Beyond the preview
Go deeper on NCT05946772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05946772.